Foghorn Therapeutics files investor presentation; no specific facts available in filing text

Foghorn Therapeutics Inc.

Form 8-K furnished under Item 7.01; presentation dated May 20, 2024.
Presentation tagged 'Unique biology, Precision therapeutics, Broad impact'.
No quantitative data, pipeline updates, or financial guidance provided in the filing.
Presentation available as Exhibit 99.1 but its content is not extracted in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.